| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |